N‐homocysteinylation of α‐synuclein promotes its aggregation and neurotoxicity
Aging Cell · 2023-03 · 22 (3)
DOI: 10.1111/acel.13745 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 27.11.2022. Verfasst von Lingyan Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The aggregation of α‐synuclein plays a pivotal role in the pathogenesis of Parkinson's disease (PD). Epidemiological evidence indicates that high level of homocysteine (Hcy) is associated with an increased risk of PD. However, the molecular mechanisms remain elusive. Here, we report that homocysteine thiolactone (HTL), a reactive thioester of Hcy, covalently modifies α‐synuclein on the K80 residue. The levels of α‐synuclein K80Hcy in the brain are increased in an age‐dependent manner in the TgA53T mice, correlating with elevated levels of Hcy and HTL in the brain during aging. The N‐homocysteinylation of α‐synuclein stimulates its aggregation and forms fibrils with enhanced seeding activity and neurotoxicity. Intrastriatal injection of homocysteinylated α‐synuclein fibrils induces more severe α‐synuclein pathology and motor deficits when compared with unmodified α‐synuclein fibrils. Increasing the levels of Hcy aggravates α‐synuclein neuropathology in a mouse model of PD. In contrast, blocking the N‐homocysteinylation of α‐synuclein ameliorates α‐synuclein pathology and degeneration of dopaminergic neurons. These findings suggest that the covalent modification of α‐synuclein by HTL promotes its aggregation. Targeting the N‐homocysteinylation of α‐synuclein could be a novel therapeutic strategy against PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Research Center for Environment and Health, Zhongnan University of Economics and Law, Wuhan, China.
- Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
- TaiKang Center for Life and Medical Science, Wuhan University, Wuhan, China.
ORCID-Profile: Lingyan Zhou, Lanxia Meng, Xingyu Zhang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Zhou, L., Guo, T., Meng, L., Zhang, X., Tian, Y., Dai, L., Niu, X., Li, Y., Liu, C., Chen, G., Liu, C., Ke, W., Zhang, Z., Bao, A., & Zhang, Z. (2023). N‐homocysteinylation of α‐synuclein promotes its aggregation and neurotoxicity. Aging Cell, 22(3). https://doi.org/10.1111/acel.13745
Vancouver
Zhou L, Guo T, Meng L, Zhang X, Tian Y, Dai L, et al. N‐homocysteinylation of α‐synuclein promotes its aggregation and neurotoxicity. Aging Cell. 2023;22(3). doi:10.1111/acel.13745
BibTeX
@article{Zhou2023,
author = {Zhou, Lingyan and Guo, Tao and Meng, Lanxia and Zhang, Xingyu and Tian, Ye and Dai, Lijun and Niu, Xuan and Li, Yiming and Liu, Congcong and Chen, Guiqin and Liu, Chaoyang and Ke, Wei and Zhang, Zhaohui and Bao, Anyu and Zhang, Zhentao},
title = {N‐homocysteinylation of α‐synuclein promotes its aggregation and neurotoxicity},
journal = {Aging Cell},
year = {2023},
volume = {22},
number = {3},
doi = {10.1111/acel.13745}
}
EUVIMED